Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.40 | -$0.34 | -$0.37 |
| Q2 2026 | 2 | -$0.38 | -$0.24 | -$0.31 |
| Q3 2026 | 1 | -$0.30 | -$0.25 | -$0.28 |
| Q4 2026 | 1 | -$0.27 | -$0.22 | -$0.24 |
| Q1 2027 | 1 | -$0.26 | -$0.22 | -$0.24 |
| Q2 2027 | 1 | -$0.24 | -$0.20 | -$0.22 |
| Q3 2027 | 1 | -$0.20 | -$0.16 | -$0.18 |
| Q4 2027 | 1 | -$0.15 | -$0.13 | -$0.14 |
Cardlytics Inc last posted its earnings results on Wednesday, March 4th, 2026. The company reported $-0.15 earnings per share for the quarter, topping analysts' consensus estimates of $-0.20667 by $0.05667. The company had revenue of 56.10 M for the quarter and had revenue of 233.27 M for the year. Cardlytics Inc has generated $-2 earnings per share over the last year ($-1.95 diluted earnings per share) and currently has a price-to-earnings ratio of -0.41. Cardlytics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/04/2026 | Q4 2025 | -$0.21 | -$0.16 | 0.05 | $54.46 M | $56.10 M |
| 11/05/2025 | Q3 2025 | -$0.07 | -$1.36 | -1.29 | $54.54 M | $52.03 M |
| 08/06/2025 | Q2 2025 | -$0.16 | -$0.18 | -0.02 | $64.02 M | $63.25 M |
| 05/07/2025 | Q1 2025 | -$0.27 | -$0.26 | 0.01 | $58.01 M | $61.90 M |
| 03/12/2025 | Q4 2024 | -$0.24 | -$0.31 | -0.07 | $63.63 M | $74.00 M |
| 11/06/2024 | Q3 2024 | -$0.33 | -$2.90 | -2.57 | $57.77 M | $67.06 M |
| 08/07/2024 | Q2 2024 | -$0.21 | -$0.09 | 0.12 | $75.39 M | $69.64 M |
| 05/08/2024 | Q1 2024 | -$0.11 | -$0.56 | -0.45 | $71.69 M | $67.61 M |
| 03/14/2024 | Q4 2023 | $0.12 | -$2.56 | -2.68 | N/A | $89.17 M |
| 11/08/2023 | Q3 2023 | $0.00 | -$0.63 | -0.63 | N/A | $79.01 M |
| 08/01/2023 | Q2 2023 | -$0.43 | -$0.67 | -0.24 | N/A | $76.70 M |
| 05/04/2023 | Q1 2023 | -$0.40 | $0.98 | 1.38 | N/A | $64.33 M |
| 03/01/2023 | Q4 2022 | -$0.53 | -$11.13 | -10.6 | N/A | $82.50 M |
| 11/01/2022 | Q3 2022 | -$0.54 | $1.50 | 2.04 | N/A | $72.71 M |
| 08/02/2022 | Q2 2022 | -$0.54 | -$3.75 | -3.21 | N/A | $75.41 M |
| 05/02/2022 | Q1 2022 | -$0.69 | $2.79 | 3.48 | N/A | $64.33 M |
| 03/01/2022 | Q4 2021 | -$0.41 | -$0.35 | 0.06 | N/A | $90.05 M |
| 11/02/2021 | Q3 2021 | -$0.50 | -$1.35 | -0.85 | N/A | $64.98 M |
| 08/03/2021 | Q2 2021 | -$0.35 | -$1.43 | -1.08 | N/A | $58.85 M |
| 05/04/2021 | Q1 2021 | -$0.28 | -$0.85 | -0.57 | N/A | $53.23 M |
In the previous quarter, Cardlytics Inc (:CDLX) reported $-0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.20667 by $0.05667.
The conference call for Cardlytics Inc's latest earnings report can be listened to online.
The conference call transcript for Cardlytics Inc's latest earnings report can be read online.
Cardlytics Inc (:CDLX) has a recorded annual revenue of $233.27 M.
Cardlytics Inc (:CDLX) has a recorded net income of $-103,488,000.Cardlytics Inc has generated $-1.95 earnings per share over the last four quarters.
Cardlytics Inc (:CDLX) has a price-to-earnings ratio of -0.41 and price/earnings-to-growth ratio is -0.01.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED